Human SLAMF6/NTB-A/CD352 protein (Recombinant) (No tag) (STJP003056)

SKU:
STJP003056
£97.50 - £291.50
Processing The item has been added

Host: E.coli
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Formulation: Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Determination Method: < 0.01 EU/Mu g of the protein by LAL method.
Gene Symbol: SLAMF6
Gene ID: 114836
Uniprot ID: SLAF6_HUMAN
Immunogen Region: Gln22-Met226
Immunogen: Recombinant Human SLAMF6/NTB-A/CD352 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln22-Met226) of Human SLAMF6/NTB-A/CD352 (Accession #NP_001171643.1) fused with a hFc tag at the C-terminus.
Immunogen Sequence: KKKEKVKKGSECSEWTWGPC TPSSKDCGMGFREGTCGAQT QRVHCKVPCNWKKEFGADCK YKFESWGACDGSTGTKARQG TLKKARYNAQCQETIRVTKP CTSKTKSKTKAKKGKGKD
Tissue Specificity Expressed by all (resting and activated) natural killer cells (NK), T- and B-lymphocytes. Increased surface expression on T-cells of systemic lupus erythematosus (SLE) patients.
Post Translational Modifications Phosphorylation in NK cells upon engagment by SLAMF6-expressing target cells is leading to receptor activation.
Function Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Triggers cytolytic activity only in natural killer cells (NK) expressing high surface densities of natural cytotoxicity receptors. Positive signaling in NK cells implicates phosphorylation of VAV1. NK cell activation seems to depend on SH2D1B and not on SH2D1A. In conjunction with SLAMF1 controls the transition between positive selection and the subsequent expansion and differentiation of the thymocytic natural killer T (NKT) cell lineage. Promotes T-cell differentiation into a helper T-cell Th17 phenotype leading to increased IL-17 secretion.the costimulatory activity requires SH2D1A. Promotes recruitment of RORC to the IL-17 promoter. In conjunction with SLAMF1 and CD84/SLAMF5 may be a negative regulator of the humoral immune response. In the absence of SH2D1A/SAP can transmit negative signals to CD4(+) T-cells and NKT cells. Negatively regulates germinal center formation by inhibiting T-cell:B-cell adhesion.the function probably implicates increased association with PTPN6/SHP-1 via ITSMs in absence of SH2D1A/SAP. However, reported to be involved in maintaining B-cell tolerance in germinal centers and in preventing autoimmunity.
Protein Name Slam Family Member 6
Activating Nk Receptor
Nk-T-B-Antigen
Ntb-A
Cd Antigen Cd352
Database Links Reactome: R-HSA-198933
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Slam Family Member 6 protein
Activating Nk Receptor protein
Nk-T-B-Antigen protein
Ntb-A protein
Cd Antigen Cd352 protein
SLAMF6 protein
KALI protein
UNQ6123 protein
PRO20080 protein

Information sourced from Uniprot.org